ミズーリ州における大うつ病性障害の臨床試験
ミズーリ州内の拠点で、大うつ病性障害に関する16件の研究が参加者を募集しています。
ミズーリ州内の都市
公式研究テキスト（英語）
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Psychiatric Care and Research Center (PCRC), O'Fallon
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/25更新 · NCT05850689Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Saint Charles
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/09/24更新 · NCT06830044Lumateperone for Late-Life Depression
- Washington University School of Medicine, St Louis
被験者募集中第3相
60歳以上 · 全性別 · 2026/09/16更新 · NCT07623135A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, St Louis
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/09/14更新 · NCT07065240ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- St. Charles Psychiatric Associates, Inc. dba Midwest Research Group, Saint Charles
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/09/14更新 · NCT07284667A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Psychiatric Care and Research Center, O'Fallon
- St. Charles Psychiatric Associates - Midwest Research Group, Saint Charles
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/09/08更新 · NCT07076407Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Washington University School of Medicine, St Louis
被験者募集中
22歳〜70歳 · 全性別 · 2026/08/28更新 · NCT06423430A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Arch Clinical Trials, LLC, St Louis
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/08/10更新 · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Arch Clinical Trials, St Louis
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/06更新 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Tekton Research, St Louis
被験者募集中第3相
18歳〜74歳 · 全性別 · 2026/08/03更新 · NCT06775379A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, O'Fallon
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/24更新 · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, O'Fallon
- Neurocrine Clinical Site, Saint Charles
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/24更新 · NCT06966401A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Midwest Research Group, Saint Charles
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/05/11更新 · NCT06524830NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits
- Washington University School of Medicine, St Louis
被験者募集中第1相健康なボランティア歓迎
18歳〜65歳 · 全性別 · 2026/04/29更新 · NCT02994433Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #127, Saint Charles
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/01/20更新 · NCT06633016A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Saint Charles
被験者募集中第4相
18歳〜65歳 · 全性別 · 2025/01/23更新 · NCT06223880ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。